Literature DB >> 4730055

Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome.

S Goldfischer, C L Moore, A B Johnson, A J Spiro, M P Valsamis, H K Wisniewski, R H Ritch, W T Norton, I Rapin, L M Gartner.   

Abstract

The cerebro-hepato-renal syndrome is a rare familial malady with cerebral, renal, and skeletal abnormalities, severe hypotonia, cirrhosis, iron and lipid storage, and death within 6 months. Correlated electron microscopic, histochemical, and biochemical studies demonstrate defects in two oxidative organelles. Peroxisomes cannot be found in hepatocytes and renal proximal tubules. In hepatocytes and cortical astrocytes, mitochondria are distorted in their appearance and glycogen stores are increased. Oxygen consumnption of brain and liver mitochondrial preparations with succinate and with substrates reducing nicotinamide adenine dinucleotide is markedly diminished, but the consumption is normal with ascorbate and tetramethylphenylenediamine, which suggests a defect in electron transport prior to the cytochromes. Histochemical studies of mitochondrial oxidation point to a defect between the succinate dehydrogenase flavoprotein and coenzyme Q, possibly in the region of nonheme iron protein.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4730055     DOI: 10.1126/science.182.4107.62

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  191 in total

Review 1.  Peroxisomal disorders: clinical, biochemical, and molecular aspects.

Authors:  R J Wanders
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells.

Authors:  S Yajima; Y Suzuki; N Shimozawa; S Yamaguchi; T Orii; Y Fujiki; T Osumi; T Hashimoto; H W Moser
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

3.  Cerebral malformation associated with metabolic disorder. A report of 2 cases.

Authors:  M Erdohazi; N D Barnes; M J Robinson; B D Lake
Journal:  Acta Neuropathol       Date:  1976-12-21       Impact factor: 17.088

4.  Transcriptional coactivator PGC-1alpha promotes peroxisomal remodeling and biogenesis.

Authors:  Alessia Bagattin; Lynne Hugendubler; Elisabetta Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

Review 5.  Intracellular traffic of newly synthesized proteins. Current understanding and future prospects.

Authors:  V R Lingappa
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

6.  Defects in oxidative phosphorylation. Biochemical investigations in skeletal muscle and expression of the lesion in other cells.

Authors:  H R Scholte; H F Busch; I E Luyt-Houwen; M H Vaandrager-Verduin; H Przyrembel; W F Arts
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

7.  Peroxisomal localization of glucose-6-phosphate dehydrogenase and pyrophosphate-stimulated dihydroxyacetone-phosphate acyltransferase in mouse kidney.

Authors:  B N Patel; M I Mackness; M J Connock
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

Review 8.  Zellweger syndrome and associated phenotypes.

Authors:  D R FitzPatrick
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

9.  Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.

Authors:  Tomohiro Kimura; Atsuko K Kimura; Mindong Ren; Bob Berno; Yang Xu; Michael Schlame; Richard M Epand
Journal:  Biochemistry       Date:  2018-03-30       Impact factor: 3.162

10.  Attenuated prostaglandin formation in peroxisomal-deficient human skin fibroblasts.

Authors:  J A Gordon; L J Warnock; A A Spector
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.